Literature DB >> 29997965

Inter-relationship among myasthenia gravis, WHO histology, and Masaoka clinical stage and effect on surgical methods in patients with thymoma: a retrospective cohort study.

Jianfei Shen1, Hongtao Tie2, Anyi Xu3, Dan Chen2, Dehua Ma1, Bo Zhang1, Chengchu Zhu1, Qingchen Wu2.   

Abstract

BACKGROUND: The aim of study is to analyze the inter-relationship among WHO histology, myasthenia gravis (MG) and Masaoka stage and to assess the feasibility of thoracoscopic surgery in thymoma patients.
METHODS: Data from 142 consecutive thymoma patients from January 2009 to March 2016 were retrospectively reviewed in our institution. Histological classification and clinical staging were assessed by WHO histology criteria and Masaoka stage. We investigated the clinical characteristics, inter-relationship among WHO histology, MG and Masaoka stage, and compared the feasibility and safety of thoracoscopic thymectomy by comparison of open thymectomy.
RESULTS: Among 142 patients, the incidence of MG was 29.6%. Compared with A and AB-type thymomas, a higher prevalence of advance clinical stage was in B1 to C-type thymomas (37/63 vs. 9/43, P<0.001), and there was an increased trend of Masaoka stage from A to C-type thymomas (P<0.001). The incidence of MG was significantly higher in AB, B1 and B2-type thymomas than other type thymomas (23/63 vs. 6/44, P=0.009) and in early Masaoka clinical stage than advanced Masaoka clinical stage (29/80 vs. 12/59, P=0.042). Thoracoscopic surgery could significantly decrease blood loss in patients with (104.06±137.36 vs. 350.91±560.79 mL, P=0.001) or without MG (91.90±77.70 vs. 266.32±292.60 mL, P=0.02), with comparable complications. Additionally, thoracoscopic surgery could achieve an equal effect on the remission of MG with open surgery (7/11 vs. 10/14, P=1.000), and Masaoka stage was significantly associated with the remission of MG after thymectomy.
CONCLUSIONS: Our study suggests that WHO histology, MG, and Masaoka stage interrelate with one another, and Masaoka stage is an important prognostic factor in remission of MG after thymectomy in thymoma patients. Thoracoscopic thymectomy could achieve an equal efficacy to open thymectomy and should be recommended as a routine surgery for patients with early Masaoka stage.

Entities:  

Keywords:  Thymoma; myasthenia gravis (MG); open thymectomy; thoracoscopic thymectomy

Year:  2018        PMID: 29997965      PMCID: PMC6006062          DOI: 10.21037/jtd.2018.05.30

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  32 in total

1.  Video-assisted thoracoscopic surgery versus sternotomy in thymectomy for thymoma and myasthenia gravis.

Authors:  Adnan Raza; Edwin Woo
Journal:  Ann Cardiothorac Surg       Date:  2016-01

Review 2.  Surgery for thymoma.

Authors:  J L Port; R J Ginsberg
Journal:  Chest Surg Clin N Am       Date:  2001-05

3.  Catastrophes during video-assisted thoracoscopic thymus surgery for myasthenia gravis.

Authors:  Berker Özkan; Alper Toker
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-05-19

4.  Comparison of oncological results for early- and advanced-stage thymomas: thoracoscopic thymectomy versus open thymectomy.

Authors:  Makoto Odaka; Takamasa Shibasaki; Daiki Kato; Shohei Mori; Hisatoshi Asano; Makoto Yamashita; Toshiaki Morikawa
Journal:  Surg Endosc       Date:  2016-06-20       Impact factor: 4.584

5.  Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies.

Authors:  Eric A Engels; Ruth M Pfeiffer
Journal:  Int J Cancer       Date:  2003-07-01       Impact factor: 7.396

6.  Thymoma and myasthenia gravis: a clinical study of 1,089 patients from Japan.

Authors:  Kazuya Kondo; Yasumasa Monden
Journal:  Ann Thorac Surg       Date:  2005-01       Impact factor: 4.330

7.  Thymoma: a clinicopathologic study based on the new World Health Organization classification.

Authors:  Kazuo Nakagawa; Hisao Asamura; Yoshihiro Matsuno; Kenji Suzuki; Haruhiko Kondo; Arafumi Maeshima; Etsuo Miyaoka; Ryosuke Tsuchiya
Journal:  J Thorac Cardiovasc Surg       Date:  2003-10       Impact factor: 5.209

8.  Bilateral thoracoscopic extended thymectomy versus sternotomy.

Authors:  Alfonso Fiorelli; Antonio Mazzella; Roberto Cascone; Francesco Paolo Caronia; Ettore Arrigo; Mario Santini
Journal:  Asian Cardiovasc Thorac Ann       Date:  2016-05-12

Review 9.  Video-assisted thoracoscopic surgery thymectomy versus open thymectomy in patients with myasthenia gravis: a meta-analysis.

Authors:  Kang Qi; Bo Wang; Bin Wang; Lian-Bin Zhang; Xiang-Yang Chu
Journal:  Acta Chir Belg       Date:  2016-06-21       Impact factor: 1.090

10.  Thirty-five-year follow-up analysis of clinical and pathologic outcomes of thymoma surgery.

Authors:  Stefano Margaritora; Alfredo Cesario; Giacomo Cusumano; Elisa Meacci; Rolando D'Angelillo; Stefano Bonassi; Giulia Carnassale; Venanzio Porziella; Adele Tessitore; Maria Letizia Vita; Libero Lauriola; Amelia Evoli; Pierluigi Granone
Journal:  Ann Thorac Surg       Date:  2010-01       Impact factor: 4.330

View more
  3 in total

1.  Relationship between anti-acetylcholine receptor antibodies and the development of post-thymectomy myasthenia gravis in patients with thymoma: a single-center experience.

Authors:  Yusuke Nabe; Teppei Hashimoto; Kanji Tanaka; Yasuhiro Fujita; Katsuma Yoshimatsu; Yukiko Nemoto; Rintaro Oyama; Hiroki Matsumiya; Masataka Mori; Masatoshi Kanayama; Akihiro Taira; Shinji Shinohara; Taiji Kuwata; Masaru Takenaka; Yuko Tashima; Koji Kuroda; Fumihiro Tanaka
Journal:  Gland Surg       Date:  2021-08

2.  Myasthenia gravis affects overall survival in patients with thymoma: an analysis of multicentre database using propensity score matching.

Authors:  Wenxin Tian; Xiao Li; Yaoguang Sun; Jun Wang; Guanchao Jiang; Hongfeng Tong
Journal:  Interact Cardiovasc Thorac Surg       Date:  2021-07-26

3.  Histotyping of Indian thymomas: A clinicopathologic study from north India.

Authors:  Prerna Guleria; Rajinder Parshad; Prabhat Singh Malik; Ruma Ray; R M Pandey; Deepali Jain
Journal:  Indian J Med Res       Date:  2019-08       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.